Predicting Responses to Neoadjuvant Chemotherapy in Breast Cancer: ACRIN 6691 Trial of Diffuse Optical Spectroscopic Imaging (DOSI)

The prospective multi-center ACRIN 6691 trial was designed to evaluate whether changes from baseline to mid-therapy in a Diffuse Optical Spectroscopic Imaging (DOSI)-derived imaging endpoint, the Tissue Optical Index (TOI), predict pathologic complete response (pCR) in women undergoing breast cancer...

全面介紹

Na minha lista:
書目詳細資料
發表在:Cancer Res
Main Authors: Tromberg, Bruce J., Zhang, Zheng, Leproux, Anaïs, O’Sullivan, Thomas D., Cerussi, Albert E., Carpenter, Philip, Mehta, Rita S., Roblyer, Darren, Yang, Wei, Paulsen, Keith D., Pogue, Brian W., Jiang, Shudong, Kaufman, Peter, Yodh AG, Arjun G., Chung, So Hyun, Schnall, Mitchell, Snyder, Bradley S., Hylton, Nola, Boas, David A., Carp, Stefan A., Isakoff, Steven J., Mankoff, David
格式: Artigo
語言:Inglês
出版: 2016
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5148152/
https://ncbi.nlm.nih.gov/pubmed/27527559
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-16-0346
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍